Neoadjuvant chemotherapy (NACT) refers to the administration of chemotherapeutic agents before the primary treatment, typically surgery, in order to reduce the size of a tumor. This approach is increasingly used in the treatment of various gynecologic cancers, including cervical, ovarian, and endometrial cancers.
